B. Riley Has Positive Forecast for Lam Research Q2 Earnings

Lam Research Corporation (NASDAQ:LRCXFree Report) – B. Riley lifted their Q2 2026 EPS estimates for shares of Lam Research in a research note issued on Wednesday, October 22nd. B. Riley analyst C. Ellis now forecasts that the semiconductor company will post earnings of $1.14 per share for the quarter, up from their prior estimate of $1.06. B. Riley has a “Buy” rating and a $175.00 price objective on the stock. The consensus estimate for Lam Research’s current full-year earnings is $3.71 per share. B. Riley also issued estimates for Lam Research’s Q3 2026 earnings at $1.09 EPS, Q4 2026 earnings at $1.13 EPS, FY2026 earnings at $4.63 EPS, Q1 2027 earnings at $1.18 EPS, Q2 2027 earnings at $1.23 EPS, Q3 2027 earnings at $1.24 EPS, Q4 2027 earnings at $1.32 EPS and FY2027 earnings at $4.97 EPS.

Other equities research analysts have also issued reports about the stock. Zacks Research upgraded shares of Lam Research from a “hold” rating to a “strong-buy” rating in a research note on Monday, October 20th. Hsbc Global Res upgraded shares of Lam Research to a “hold” rating in a research note on Tuesday, September 30th. Rothschild & Co Redburn boosted their target price on shares of Lam Research from $140.00 to $150.00 and gave the company a “buy” rating in a research note on Tuesday, October 14th. Wall Street Zen upgraded shares of Lam Research from a “hold” rating to a “buy” rating in a research note on Saturday, October 4th. Finally, Barclays set a $142.00 price objective on shares of Lam Research and gave the company an “equal weight” rating in a research report on Monday. One equities research analyst has rated the stock with a Strong Buy rating, twenty-six have assigned a Buy rating and eight have given a Hold rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $147.21.

View Our Latest Stock Analysis on LRCX

Lam Research Price Performance

Shares of LRCX opened at $151.68 on Friday. The firm has a market cap of $191.27 billion, a PE ratio of 33.41, a P/E/G ratio of 1.76 and a beta of 1.84. The company has a current ratio of 2.21, a quick ratio of 1.55 and a debt-to-equity ratio of 0.37. The firm has a fifty day simple moving average of $123.23 and a two-hundred day simple moving average of $99.60. Lam Research has a 1-year low of $56.32 and a 1-year high of $153.70.

Lam Research (NASDAQ:LRCXGet Free Report) last announced its earnings results on Wednesday, October 22nd. The semiconductor company reported $1.26 earnings per share for the quarter, beating analysts’ consensus estimates of $1.22 by $0.04. The business had revenue of $5.32 billion during the quarter, compared to analyst estimates of $5.23 billion. Lam Research had a net margin of 29.66% and a return on equity of 60.60%. The company’s quarterly revenue was up 27.7% compared to the same quarter last year. During the same period in the previous year, the business earned $0.86 EPS. Lam Research has set its Q2 2026 guidance at 1.050-1.250 EPS.

Lam Research Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, October 15th. Stockholders of record on Wednesday, September 24th were given a dividend of $0.26 per share. This represents a $1.04 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date of this dividend was Wednesday, September 24th. This is a positive change from Lam Research’s previous quarterly dividend of $0.23. Lam Research’s payout ratio is presently 22.91%.

Insider Activity

In related news, SVP Vahid Vahedi sold 52,190 shares of the company’s stock in a transaction on Monday, October 13th. The shares were sold at an average price of $138.90, for a total value of $7,249,191.00. Following the completion of the transaction, the senior vice president owned 251,047 shares of the company’s stock, valued at approximately $34,870,428.30. This represents a 17.21% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. 0.31% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Several hedge funds have recently bought and sold shares of the company. MGO One Seven LLC boosted its holdings in Lam Research by 110.3% in the 3rd quarter. MGO One Seven LLC now owns 33,396 shares of the semiconductor company’s stock worth $4,472,000 after buying an additional 17,514 shares during the period. Meeder Asset Management Inc. boosted its holdings in Lam Research by 913.1% in the 3rd quarter. Meeder Asset Management Inc. now owns 7,051 shares of the semiconductor company’s stock worth $944,000 after buying an additional 6,355 shares during the period. Citizens Financial Group Inc. RI boosted its holdings in Lam Research by 12.9% in the 3rd quarter. Citizens Financial Group Inc. RI now owns 17,500 shares of the semiconductor company’s stock worth $2,343,000 after buying an additional 1,993 shares during the period. Tema Etfs LLC boosted its holdings in Lam Research by 120.9% in the 3rd quarter. Tema Etfs LLC now owns 36,085 shares of the semiconductor company’s stock worth $4,832,000 after buying an additional 19,753 shares during the period. Finally, New York State Teachers Retirement System boosted its holdings in Lam Research by 2.2% in the 3rd quarter. New York State Teachers Retirement System now owns 1,067,446 shares of the semiconductor company’s stock worth $142,931,000 after buying an additional 22,631 shares during the period. Institutional investors own 84.61% of the company’s stock.

About Lam Research

(Get Free Report)

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.

Further Reading

Earnings History and Estimates for Lam Research (NASDAQ:LRCX)

Receive News & Ratings for Lam Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lam Research and related companies with MarketBeat.com's FREE daily email newsletter.